The session on ‘Sustainable packaging solutions in pharma’ addressed a challenge that is increasingly critical, how to reduce environmental footprint while ensuring compliance, safety, and cost-effectiveness. Manjunath Nadella, Assistant VP & Head – Packaging Development, Strides Pharma Science began by pointing out that packaging is no longer just about protecting medicines; it is about responding to global sustainability imperatives, regulatory demands and patient expectations.
He gave examples of sustainable design approaches and showcased how significant improvements can be achieved through simple interventions. For e.g. by reducing bottle sizes from 100cc to 60cc, companies can cut plastic use by 40 per cent, lower logistics costs by 30 per cent, and achieve similar reductions in carbon footprint. Similarly, the move from standard to perforated blister packs reduces material use by 30 per cent, while improving efficiency in transportation and storage. These changes support sustainability goals and bring tangible economic benefits.
Nadella also explored innovative packaging concepts that go beyond material reduction. One such example was integrating patient literature directly into printed cartons, eliminating the need for separate leaflets. This reduces both material costs and man-hours in packaging operations. Another example was the introduction of press-fit closures as an alternative to child-resistant closures. With 50 per cent less polymer use, cost advantages, and easier patient handling, these closures demonstrate how sustainability and convenience can go hand in hand while still complying with CRSF guidance.
He also highlighted technology as a major enabler of sustainable packaging. The shift from paper-based medication guides and printed literature to digital alternatives such as QR codes and electronic patient information leaflets can significantly cut paper usage.
The session concluded with a clear message, sustainable packaging is no longer optional, it is essential. By adopting smarter designs, leveraging technology and integrating sustainability, pharma companies can meet regulatory expectations, reduce costs and play their part in addressing global environmental challenges.